SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort

NCT05067400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 615

Last updated 2023-11-27

No results posted yet for this study

Summary

Prospective, observational SARS-CoV2 serological surveillance single London HIV outpatient center study using NHS participants

Conditions

Sponsors & Collaborators

  • Roche Diagnostics GmbH

    collaborator INDUSTRY
  • Royal Free Hospital NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Tristan Barber, MBBChir · Royal Free London NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067400 on ClinicalTrials.gov